Literature DB >> 638617

Aluminium toxicity during regular haemodialysis.

H L Elliott, F Dryburgh, G S Fell, S Sabet, A I Macdougall.   

Abstract

In the west of Scotland the incidence of dialysis encephalopathy has been confined to three geographical areas where the concentration of aluminium in the water supply is greatly increased owing to the addition of aluminium sulphate. Eight patients with encephalopathy who dialysed at home in these areas had greatly increased serum aluminium concentrations, and a significant correlation was found between serum aluminium concentrations and the concentrations of aluminium in the water supply. This study provides further evidence that the dialysis encephalopathy syndrome is due to aluminium intoxication, the major source of aluminium being the water supply from which dialysis fluid prepared.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638617      PMCID: PMC1604357          DOI: 10.1136/bmj.1.6120.1101

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  The dialysis encephalopathy syndrome. Possible aluminum intoxication.

Authors:  A C Alfrey; G R LeGendre; W D Kaehny
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

2.  Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.

Authors:  M M Platts; G C Goode; J S Hislop
Journal:  Br Med J       Date:  1977-09-10

3.  Dialysis dementia: recovery after transplantation.

Authors:  P Sullivan; D J Murnaghan; N Callaghan
Journal:  Br Med J       Date:  1977-09-17

4.  Letter: Haemodialysis encephalopathy: Possible role of phosphate depletion.

Authors:  A M Pierides; M K Ward; D N Kerr
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

5.  Letter: Aluminum and dialysis dementia.

Authors:  J A Flendrig; H Kruis; H A Das
Journal:  Lancet       Date:  1976-06-05       Impact factor: 79.321

  5 in total
  19 in total

1.  Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.

Authors:  H A Ellis; J H McCarthy; J Herrington
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

2.  The response of the normochromic normocytic anaemia of chronic renal failure to desferrioxamine.

Authors:  A A O'Brien; D P Moore; J A Keogh
Journal:  Ir J Med Sci       Date:  1987-08       Impact factor: 1.568

3.  Seizures after infusion of factor VIII.

Authors:  H L Elliott; G S Fell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-11

4.  Aluminium hydroxide intake: real risk of aluminium toxicity.

Authors:  J B Cannata; J D Briggs; B J Junor; G S Fell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-18

Review 5.  Toxic substances and the nervous system: the role of clinical observation.

Authors:  P M Le Quesne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

6.  Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

Authors:  I S Parkinson; M K Ward; D N Kerr
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

7.  Aluminum transfer as glutamate complex through blood-brain barrier. Possible implication in dialysis encephalopathy.

Authors:  R Deloncle; O Guillard; F Clanet; P Courtois; A Piriou
Journal:  Biol Trace Elem Res       Date:  1990-04       Impact factor: 3.738

8.  Aluminium in the blood and urine of industrially exposed workers.

Authors:  B Sjögren; I Lundberg; V Lidums
Journal:  Br J Ind Med       Date:  1983-08

9.  Dialysis myopathy. Report of 13 cases.

Authors:  J Bautista; E Gil-Necija; J Castilla; I Chinchon; E Rafel
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

10.  Alterations of phenytoin protein binding with in vivo haemodialysis in dialysis encephalopathy.

Authors:  W H Steele; J R Lawrence; H L Elliott; B Whiting
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.